Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017 (H.R. 1187) Re-Introduced in U.S. House of Representatives, February 2017
This is a similar bill to the one known in the 112th Congress (2011-2012) as HR 2239, in the 113th Congress (2013-2014) as HR 842, and in the 114th Congress (2015-2016) as HR 2311, which did not pass. IBS Impact thanks IFFGD for its consistent work over many years in bringing this historically bipartisan bill to fruition and urges U.S. citizen IBS Impact members and site visitors to advocate for this landmark legislation on behalf of people with IBS and related disorders.
IFFGD announced publicly on March 7, 2017 that HR 1187 was introduced into the 115th Congress (2017-2018) on February 16, 2017 by Rep. F. James Sensenbrenner (R-WI-5), who also was the initial sponsor of all previous versions. In March 2017, Rep. Mark Pocan (D-WI-2), joined him as the first co-sponsor. In June 2017, Rep. Eliot Engel (D-NY-16) and Rep. Dave Loebsack (D-IA-2) signed on. Reps. Pocan, Engel, and Loebsack were all co-sponsors of the most recent previous version as well.
If you are a constituent of any of these representatives, please write or call or post on their social media to thank them for their ongoing support of the functional gastrointestinal and motility disorders community.
U.S. citizens in other districts, please contact your own representatives to ask them to co-sponsor this act.
The text and current status of the legislation can be found here:
IFFGD’s HR 1187 resources can be found here:
More information on how to advocate for this act is expected to be available soon. Check back on this site, our blog at http://ibsimpact.wordpress.com or IBS Impact on Facebook Twitter for updates as they occur.
Last updated: June 2017